|Bid||81.16 x 800|
|Ask||81.16 x 800|
|Day's Range||80.53 - 82.52|
|52 Week Range||43.40 - 90.15|
|Beta (5Y Monthly)||1.77|
|PE Ratio (TTM)||15.38|
|Earnings Date||May 04, 2020 - May 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||85.60|
Zacks.com featured highlights include: Tempur Sealy International, Twin River Worldwide, Rite Aid, DaVita and United Therapeutics
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 12.05% and -0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, NY / ACCESSWIRE / February 10, 2020 / DaVita, Inc. (NYSE:DVA) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 10, 2020 at 5:00 PM Eastern ...
Today we're going to take a look at the well-established DaVita Inc. (NYSE:DVA). The company's stock saw a significant...
DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.